AzTrials
AzTrials

PainNCT07323797

Overlapping Pelvic and Temporomandibular Pain: A Cross-Sectional Analysis of Psychosocial and Sensitization Mechanisms

An observational study of Pain, run by University of Valencia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to learn whether pain in the temporomandibular joint is associated with pelvic pain in adults, and to explore psychosocial and pain sensitization factors that may contribute to both conditions. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pain
How many people
133 participants
Where
1 siteSpain
Study dates
9 Sep 2025to 1 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Study participants will be selected from the adult general population experiencing chronic pain. The study population includes individuals aged 18 years or older who report pain in the orofacial (temporomandibular) region, the pelvic region, both regions, or chronic pain in other body areas without involvement of the temporomandibular or pelvic regions. Participants must be able to read and understand Spanish and provide informed consent.

Who may be able to join

  • Age 18 years or older.
  • Presence of chronic pain
  • Ability to complete self-administered questionnaires.
  • Signed informed consent provided prior to participation.

Who cannot join

  • Inability to read or understand Spanish.
  • Failure or refusal to provide informed consent for participation in the study.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Faculty of Physiotherapy. University of Valencia

    Valencia, Valencia, 46010

Other trials in Spain

About this study

The goal of this observational study is to learn whether pain in the temporomandibular joint is associated with pelvic pain in adults, and to explore psychosocial and pain sensitization factors that may contribute to both conditions.

The main questions it aims to answer are:

Read more

Is temporomandibular joint dysfunction associated with pelvic pain in the adult population? Are psychosocial factors and indicators of central pain sensitization related to the co-occurrence of these pain conditions?

Participants will complete standardized, self-administered questionnaires at a single point in time that assess:

Temporomandibular joint symptoms Pelvic pain symptoms Psychosocial factors and pain sensitization features

No treatments or interventions will be given as part of this study.

Read the detailed description

Chronic pain is a major public health concern due to its high prevalence and its significant impact on quality of life, daily functioning, and overall well-being. Among chronic pain types, nociplastic pain is characterized by persistent pain in the absence of clear tissue damage and is associated with alterations in central pain processing, including central sensitization and dysfunction of the central nervous system. These alterations may manifest as widespread pain sensitivity, autonomic dysregulation, and changes in sensory integration, contributing to long-lasting and diffuse pain experiences.

Individuals with chronic pain frequently report pain in more than one body region, a phenomenon known as Chronic Overlapping Pain Conditions (COPC). The presence of overlapping pain conditions suggests shared underlying mechanisms, such as central sensitization and common psychosocial modulators, which may explain the co-occurrence of different chronic pain syndromes. In this context, temporomandibular joint (TMJ) pain and pelvic pain are of particular interest, as emerging evidence indicates a possible association between these conditions.

Given the existing evidence linking chronic pain conditions across different body regions, further investigation into the co-occurrence of TMJ dysfunction and pelvic pain is warranted. This observational, cross-sectional study aims to characterize the association between these two pain conditions in an adult population and to explore demographic, socioeconomic, psychosocial, and pain-related factors that may help explain their relationship. By improving understanding of shared pain mechanisms, this research seeks to inform future clinical approaches that are more comprehensive and integrative.

Data will be collected at a single time point using standardized, self-administered questionnaires, in accordance with the STROBE guidelines for observational research. Demographic variables will include age, sex, and-among female participants-reproductive and hormonal history (pregnancy, childbirth, episiotomy, cesarean section, and menopausal status). Additional variables will include marital status, current medication use, height, weight, smoking status, physical activity levels, and the duration of orofacial and/or pelvic pain symptoms. Socioeconomic factors such as educational level, classified according to the International Standard Classification of Education (ISCED), and monthly household income, categorized into national income deciles, will also be recorded.

The co-occurrence of chronic pain conditions will be assessed using the Chronic Overlapping Pain Conditions Screener (COPC-S). Pain intensity will be measured using the Numerical Rating Scale (NRS), while fear of movement related to orofacial pain will be evaluated using the Tampa Scale of Kinesiophobia adapted for temporomandibular disorders (TSK-TMD). The presence of central sensitization symptoms will be assessed with the Central Sensitization Inventory (CSI). Psychosocial influences on pain will be examined through measures of health-related quality of life (Short Form-12), perceived stress (Perceived Stress Scale-10), and anxiety (short form of the State-Trait Anxiety Inventory, STAI-6).

By systematically examining the overlap between temporomandibular and pelvic pain and their associated biopsychosocial factors, this study aims to provide preliminary evidence on shared mechanisms of chronic pain. The findings may support the development of more holistic assessment strategies and integrated clinical interventions for individuals experiencing chronic overlapping pain conditions.

Conditions
Pain
Keywords
Chronic Pain, Comorbidity, Cross-sectional, Pelvic Pain, Temporomandibular Joint Disorders
Medical subject headings
Pain, Chronic Pain, Pelvic Pain, Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07323797
Study groupRoleWhat they receive
Chronic PainAdults with chronic pain who do not report pain in the pelvic region or the temporomandibular joint.
Temporomandibular Pain OnlyAdults with chronic pain who report pain or dysfunction in the temporomandibular joint region but do not report pelvic pain.
Pelvic Pain OnlyAdults with chronic pain who report pelvic pain but do not report temporomandibular joint pain.
Overlapping Pelvic and Temporomandibular PainAdults with chronic pain who report both pelvic pain and temporomandibular joint pain, consistent with chronic overlapping pain conditions.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Co-occurrence of Chronic Pain Conditions

    The presence and degree of overlapping chronic pain conditions will be assessed using the Chronic Overlapping Pain Conditions Screener (COPC-S). This validated tool identifies co-occurring pain conditions across different body regions and will be used to classify participants into pain groups and to quantify overlap between temporomandibular and pelvic pain.

    Measured: Baseline

Secondary outcomes (6)
  1. Pain Intensity

    Pain intensity in the temporomandibular and/or pelvic regions will be measured using the Numerical Rating Scale (NRS). Participants will rate their pain intensity on an 11-point scale ranging from 0 (no pain) to 10 (worst pain imaginable). The NRS is a widely used and validated measure of pain severity in chronic pain populations.

    Measured: Baseline

  2. Kinesiophobia Related to Temporomandibular Pain

    Fear of movement related to orofacial pain will be assessed using the Tampa Scale of Kinesiophobia for Temporomandibular Disorders (TSK-TMD), a validated and culturally adapted version of the original Tampa Scale of Kinesiophobia. The TSK-TMD is a self-reported questionnaire that evaluates pain-related fear and avoidance behaviors associated with jaw movement in individuals with temporomandibular disorders. Total scores range from 17 to 68, with higher scores indicating greater levels of kinesiophobia (worse outcome).

    Measured: Baseline

  3. Central Sensitization Symptoms

    Central sensitization-related symptoms will be assessed using the Central Sensitization Inventory (CSI), Spanish-validated version. The CSI is a self-reported questionnaire designed to evaluate symptoms associated with altered central pain processing, including widespread pain, fatigue, sleep disturbances, and cognitive difficulties. The total score ranges from 0 to 100, with higher scores indicating a greater severity of central sensitization symptoms (worse outcome).

    Measured: Baseline

  4. Health-Related Quality of Life

    Health-related quality of life will be assessed using the Short Form-12 Health Survey (SF-12), Spanish-validated version. The SF-12 is a self-reported instrument that generates two composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS), reflecting physical and mental aspects of overall functioning and well-being. Each composite score is standardized to range from 0 to 100, with higher scores indicating better perceived health status (better outcome).

    Measured: Baseline

  5. Perceived Stress

    Perceived stress levels will be assessed using the Perceived Stress Scale-10 (PSS-10), a self-reported questionnaire that evaluates the degree to which individuals perceive their lives as stressful during the past month. The total score ranges from 0 to 40, with higher scores indicating greater perceived stress (worse outcome).

    Measured: Baseline

  6. Anxiety Levels

    Anxiety will be assessed using the State-Trait Anxiety Inventory, 6-item short form (STAI-6), a self-reported instrument designed to measure current (state) anxiety symptoms and emotional tension. Total scores range from 6 to 24, with higher scores indicating greater anxiety levels (worse outcome).

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2026
  2. Study start9 Sep 2025
  3. Primary completion1 Nov 2025
  4. Study completion1 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
133 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07323797
Sponsor's protocol ID
2025-FIS-4199837
Status last verified
Dec 2025
First submitted
17 Dec 2025
Last updated
7 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pain, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Co-occurrence of Chronic Pain Conditions (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in